Big news this morning with acquisition of Definiens by MedImmune, strengthening MedImmune's focus on the discovery of novel predictive biomarkers in immune-oncology. Good news for patients and their providers. Tuesday, 4 November 2014 -...

Alongside genomics, Tissue Phenomics™ is a key driver in the growth of personalized medicine and the improvement of patient lives. The unique ability of Tissue Phenomics’ to extract detailed quantitative data from tissue images and...

Overview Program Agenda Accommodations San Francisco Definiens invites you to attend The International Symposium for Tissue Phenomics™. Enjoy expert presentations and...